Bml Capital Management, LLC Ikena Oncology, Inc. Transaction History
Bml Capital Management, LLC
- $161 Billion
- Q4 2024
A detailed history of Bml Capital Management, LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 3,585,866 shares of IKNA stock, worth $5.34 Million. This represents 3.65% of its overall portfolio holdings.
Number of Shares
3,585,866
Previous 723,288
395.77%
Holding current value
$5.34 Million
Previous $1.25 Billion
369.98%
% of portfolio
3.65%
Previous 0.74%
Shares
3 transactions
Others Institutions Holding IKNA
# of Institutions
56Shares Held
32.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$7.48 Million1.36% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$6.1 Million2.87% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$5.97 Million0.25% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.27 Million0.16% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.35 Million5.63% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $54M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...